Funded Tech Companies
Tikva Allocell
Headquartered in Singapore, Tikva Allocell raised its funding from Kantharos Capital and private investors.
Company Overview
Company Name
Tikva Allocell
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
61 Biopolis Dr, Proteos
Singapore, 138673
Singapore
Singapore, 138673
Singapore
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Tikva Allocell is focused on creating therapy using our proprietary IP protected platform to drive the next breakthrough in cancer therapy. At Tikva Allocell we inspire hope today, for a better tomorrow. Tikva Allocell is established by a seasoned cell therapy development team with practical knowledge and experience, to develop effective, available and affordable "off-the-shelf" T cell therapies by leveraging excellent safety profile of Allogeneic Epstein-Barr Virus (EBV)-Specific T cells (ALLO EBVST) and proprietary IP protected technologies that enhance the T cell performance to treat cancer.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/22/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ivan Horak
Chief Operating Officer
Craig Loren
Co-Founder
Malcolm Brenner
Co-Founder
Helen Heslop
Co-Founder
Cliona Rooney
Company Investors
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs